New approach increases the likelihood of detecting antiphospholipid syndrome

The Geneva University Hospitals, the University of Geneva and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholipid syndrome.

Related Keywords

Geneva ,Genè ,Switzerland ,Karim Brandt ,Emily Henderson ,Geneva University Hospitals ,Cardiology Department ,National Centre For Scientific Research ,University Of Geneva ,Lab Diagnostics Automation ,Lab Diagnostics Automation Industry ,Department Of Medicine ,Automation Industry Focus ,National Centre ,Scientific Research ,Antibodies ,Antiphospholipid Syndrome ,Yndrome ,Flood ,Contraception ,Iagnostics ,Heart ,Medicine ,Olecule ,Pregnancy ,Research ,Hrombosis ,